BIOMARIN PHARMACEUTICAL INC Payments to Acquire Property, Plant, and Equipment in USD from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from Q1 2010 to Q1 2025.
  • Biomarin Pharmaceutical Inc Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2025 was $16.8M, a 35.8% decline year-over-year.
  • Biomarin Pharmaceutical Inc annual Payments to Acquire Property, Plant, and Equipment for 2024 was $85.4M, a 11.7% decline from 2023.
  • Biomarin Pharmaceutical Inc annual Payments to Acquire Property, Plant, and Equipment for 2023 was $96.7M, a 20.1% decline from 2022.
  • Biomarin Pharmaceutical Inc annual Payments to Acquire Property, Plant, and Equipment for 2022 was $121M, a 26.6% increase from 2021.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)

BIOMARIN PHARMACEUTICAL INC Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $16.8M -$9.34M -35.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-02
Q1 2024 $26.1M +$1.65M +6.74% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-02
Q1 2023 $24.5M -$4.36M -15.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q1 2022 $28.8M +$3.31M +13% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q1 2021 $25.5M -$15M -37.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q1 2020 $40.6M +$11.8M +41% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q1 2019 $28.8M -$1.41M -4.67% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q1 2018 $30.2M -$38.9M -56.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q1 2017 $69.1M +$23.9M +52.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q1 2016 $45.2M +$1.37M +3.13% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q1 2015 $43.8M +$20.2M +85.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q2 2014 $20M Apr 1, 2014 Jun 30, 2014 10-Q 2014-07-31
Q1 2014 $23.6M +$11.8M +99.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q1 2013 $11.8M +$5.65M +91.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q1 2012 $6.18M -$62K -0.99% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-29
Q1 2011 $6.24M -$7.87M -55.8% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-30
Q1 2010 $14.1M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-29

BIOMARIN PHARMACEUTICAL INC Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $85.4M -$11.3M -11.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-24
2023 $96.7M -$24.3M -20.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-24
2022 $121M +$25.4M +26.6% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-24
2021 $95.6M -$18.7M -16.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $114M -$30.7M -21.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $145M +$406K +0.28% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $145M -$54.6M -27.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $199M +$50.8M +34.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $148M -$79.3M -34.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $228M +$111M +94.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
2014 $117M +$51.9M +79.6% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
2013 $65.2M +$20.6M +46.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $44.6M -$28.6M -39.1% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 $73.2M +$23.8M +48% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-26
2010 $49.5M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.